In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope

Nature Medicine

Volumn 6, Issue 3, 2000, Pages 337-342

  Anderson, Robert P ^a   Degano, Pilar ^a   Godkin, Andrew J ^a   Jewell, Derek P ^a   Hill, Adrian V S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; EPITOPE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; CELIAC DISEASE; CELL FUNCTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOTHERAPY; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGE OF ONSET; AMINO ACID SEQUENCE; CELIAC DISEASE; CELLS, CULTURED; EPITOPES; FEMALE; GLIADIN; GREAT BRITAIN; HLA-DQ ANTIGENS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PREVALENCE; T-LYMPHOCYTES; TRANSGLUTAMINASES;

HORDEUM VULGARE SUBSP. VULGARE; SECALE CEREALE; TRITICUM AESTIVUM;

EID: 0034066695     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/73200     Document Type: Article

References (22)

1. Hin, H., Bird, C., Fisher, P., Mahy, N. & Jewell, D. Coeliac disease in primary care: case finding study. Br. Med. J. 318, 164-167 (1999).
2. Kendall, M., Schneider, R., Cox, P. & Hawkins, C. Gluten subfractionation in coeliac disease. Lancet 2, 1065-1067 (1972).
3. Sollid, L.M., Thorsby, E. HLA susceptibility genes in celiac disease: genetic mapping and role in pathogenesis. Gastroenterol. 105, 910-922 (1993).
4. Molberg, O. et al. Gliadin specific, HLA DQ2-restricted T cells are commonly found in small intestinal biopsies from coeliac disease patients, but not from controls. Scand. J. Immunol. 46, 103-109 (1997).
5. van der Wal, Y. et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol. 161, 1585-1588 (1998).
6. Sjostrom, H. et al. Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition. Scand. J. Immunol. 48, 111-115 (1998).
7. Mantzaris, C. & Jewell, D. In vivo toxicity of a synthetic dodecapeptide from A gliadin in patients with coeliac disease. Scand. J. Gastroenterol. 26, 392-398 (1991).
8. de Ritis, G. et al. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. Gastroenterology 94, 41-49 (1988).
9. Mauri, L. et al. In vitro activities of A-gliadin-related synthetic peptides. Scand. J. Gastroenterol. 31, 247-253 (1996).
10. Molberg, O. et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med. 4, 713-717 (1998).
11. Kasarda, D. et al. Nucleic acid (cDNA) and amino acid sequence of α-type gliadins from wheat (Tricetum aestivum). Proc. Natl. Acad. Sci. USA B1, 4712-4716 (1984).
12. Gutgemann, I., Fahrer, A., Altman, J., Davis, M. & Chien, Y-h. Induction of rapid T cell activation and tolerance by systemic presentation of orally administered antigen. Immunity 8, 667-673 (1998).
13. Greenbergm, C.S., Birckbichlerm, P. & Ricem, R. Transglutaminases: multifunctional cross-linking enzymes that stablize tissues. FASEB J. 5, 3071-3077 (1991).
14. Lehmann, P.V., Forsthuber, T., Miller, A. & Serzarz, E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature 359, 155-157 (1992).
15. Moskophidis, D., Lechner, F., Pircher, H. & Zinkernagel, R. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 362, 758-761 (1993).
16. Lahat, N. et al. Cytokine profile in coeliac disease. Scand. J. Immunol. 49, 441-446 (1999).
17. Vartdal, F. et al. The binding motif of the disease associated HLA-DQ (α1*0501, β1*0201) molecule. Eur. J. Immunol. 26, 2764-2772 (1996).
18. Ward, R. Codex alimentarius-the proposed gluten-free standard (position paper) (The Coeliac Society of the United Kingdom, High Wycombe, UK, 1999).
19. Bunce, M. et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46, 355-367 (1995).
20. Olerup, O., Aldener, A. & Fogdell, A. HLA-DQB1 and DQA1 typing by PCR amplification with sequence-specific primers in 2 hours. Tissue Antigens 41, 119-134 (1993).
21. Mullighan, C.G., Bunce, M. & Welsh, K.I. High-resolution HLA-DQB1 typing using the polymerase chain reaction and sequence-specific primers. Tissue Antigens. 50, 688-692 (1997).
22. Plebanski, M. et al. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I restricted epitope with recombinant carriers suitable for human use. Eur. J. Immunol. 28, 4345-4355 (1998).